PMN Company Profile and Key Details

Q: Who are the executives of PMN?

Dr. Ernest D. Bush Ph.D.Head of Pharmacology/Toxicology & Senior ConsultantMr. Dennis Chen Ph.D.Head of Manufacturing & Senior ConsultantDr. Larry Douglas Altstiel M.D., Ph.D.Chief Medical OfficerMr. Gavin T. MalenfantChief Operating OfficerDr. Gail M. Farfel Ph.D.Chief Executive Officer & DirectorDr. David Wishart Ph.D.Chief Physics OfficerDr. Neil R. Cashman M.D.Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & DirectorDr. Johanne Kaplan Ph.D.Chief Devel. OfficerMr. Eugene WilliamsCo-Founder & Chairman

NASDAQ : PMN

ProMIS Neurosciences

$11.07

0.06+0.54%

At Close 4:00 PM

66.96

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

ProMIS Neurosciences, Inc. (PMN) stock surged +0.54%, trading at $11.07 on NASDAQ, up from the previous close of $11.01. The stock opened at $11.05, fluctuating between $11.01 and $11.30 in the recent session.

Stock Snapshot

11.01

Prev. Close

14.47M

Market Cap

11.01

Day Low

-0.49

P/E Ratio

-22.61

EPS (TTM)

-0.57

Cash Flow per Share

11.05

Open

1.31M

Number of Shares

11.3

Day High

63.06%

Free Float in %

0.2

Book Value

32.5K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 04, 2026	11.05	11.42	11.01	11.07	32.7K
Apr 30, 2026	11.02	11.49	10.96	11.04	29.3K
Apr 29, 2026	10.95	11.46	10.85	11.15	34.61K
Apr 28, 2026	11.35	11.50	10.79	10.85	34.12K
Apr 27, 2026	11.24	11.60	11.01	11.10	45.72K
Apr 23, 2026	11.34	11.69	10.88	10.88	20.55K
Apr 22, 2026	10.79	11.90	10.79	11.11	31.9K
Apr 21, 2026	11.36	11.49	10.53	10.73	53.82K
Apr 20, 2026	11.92	12.00	11.10	11.45	57.3K
Apr 17, 2026	11.99	12.30	11.25	11.53	35.53K
Apr 16, 2026	12.01	12.63	11.22	11.84	88.34K
Apr 14, 2026	12.92	13.40	11.90	12.05	17.22K
Apr 13, 2026	12.65	13.80	12.65	12.92	35.7K
Apr 10, 2026	11.88	13.23	11.88	12.60	35.48K
Apr 09, 2026	10.63	12.77	10.63	12.50	47.98K
Apr 08, 2026	11.81	11.84	10.60	10.70	23.48K
Apr 07, 2026	10.76	11.29	10.60	10.88	32.31K
Apr 06, 2026	12.70	13.13	10.57	10.96	169.88K
Apr 02, 2026	12.95	13.50	12.51	12.51	32.52K
Apr 01, 2026	12.85	13.90	12.85	13.00	12.83K

Contact Details

Toronto, ON M4S 3E2

Canada

https://www.promisneurosciences.com 416 847 6898

About Company

ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

Stock Peers

ARGX

27.59+3.52%

argenx SE$811.09 REGN

7.79+1.11%

Regeneron Pharmaceuticals, Inc.$709.21 UTHR

10.82+1.90%

United Therapeutics Corporation$581.22 MDGL

4.94002+0.96%

Madrigal Pharmaceuticals, Inc.$518.66 VRTX

5.93+1.40%

Vertex Pharmaceuticals Incorporated$429.85 PRAX

13.41+4.14%

Praxis Precision Medicines, Inc.$337.61 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

1.815+0.61%

Alnylam Pharmaceuticals, Inc.$297.93 KRYS

20.91+7.86%

Krystal Biotech, Inc.$286.95 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current ProMIS Neurosciences, Inc. (PMN) stock price?

ProMIS Neurosciences, Inc. (NASDAQ: PMN) stock price is $11.07 in the last trading session. During the trading session, PMN stock reached the peak price of $11.30 while $11.01 was the lowest point it dropped to. The percentage change in PMN stock occurred in the recent session was 0.54% while the dollar amount for the price change in PMN stock was $0.06.

PMN's industry and sector of operation?

The NASDAQ listed PMN is part of Biotechnology industry that operates in the broader Healthcare sector. ProMIS Neurosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PMN?

Dr. Ernest D. Bush Ph.D.
Head of Pharmacology/Toxicology & Senior Consultant
Mr. Dennis Chen Ph.D.
Head of Manufacturing & Senior Consultant
Dr. Larry Douglas Altstiel M.D., Ph.D.
Chief Medical Officer
Mr. Gavin T. Malenfant
Chief Operating Officer
Dr. Gail M. Farfel Ph.D.
Chief Executive Officer & Director
Dr. David Wishart Ph.D.
Chief Physics Officer
Dr. Neil R. Cashman M.D.
Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director
Dr. Johanne Kaplan Ph.D.
Chief Devel. Officer
Mr. Eugene Williams
Co-Founder & Chairman

How PMN did perform over past 52-week?

PMN's closing price is 76.56% higher than its 52-week low of $6.27 where as its distance from 52-week high of $39.75 is -72.15%.

How many employees does PMN have?

Number of PMN employees currently stands at 7.

Link for PMN official website?

Official Website of PMN is: https://www.promisneurosciences.com

How do I contact PMN?

PMN could be contacted at phone 416 847 6898 and can also be accessed through its website. PMN operates from 1920 Yonge Street, Toronto, ON M4S 3E2, Canada.

How many shares of PMN are traded daily?

PMN stock volume for the day was 32.5K shares. The average number of PMN shares traded daily for last 3 months was 45.56K.

What is the market cap of PMN currently?

The market value of PMN currently stands at $14.47M with its latest stock price at $11.07 and 1.31M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	7
Beta	-0.4
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	7
Beta	-0.4
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

PMN Company Profile and Key Details

ProMIS Neurosciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Dividend & Fair Value

Valuation Metrics

Key Takeaways

Price Forecast & Outlook